Venkat Sethuraman, PhD

ZS Associates


How Pharma Can Work with the FDA to Embrace Innovation and Overcome Its “Adoptaphobia”

March 25, 2019

FDA commissioner Scott Gottlieb criticized pharmaceutical companies and clinical research organizations for being slow to adapt innovations in clinical research, claiming that the business model adopted just isn’t compatible with the kind of changes that certain innovations can enable.

How Data and Analytics Can Improve Clinical Trial Feasibility

September 24, 2018

These seven key building blocks for success are outlined to help companies develop and implement a data-and-analytics-driven approach to clinical trial feasibility.